NasdaqGS:CLBTSoftware
Cellebrite DI (NasdaqGS:CLBT): Reassessing Valuation After Well‑Received Earnings and Guardian Platform Growth
Cellebrite DI (NasdaqGS:CLBT) just delivered a quarterly update that the market clearly liked, with shares jumping about 20% as investors responded to stronger execution and accelerating momentum in its Guardian investigative platform.
See our latest analysis for Cellebrite DI.
That earnings pop sits on top of a 1 month share price return of 18.7% and a 90 day gain of 7%, even though the year to date share price return is still negative and the 1 year total shareholder return is slightly in...